Earnings Feed
Start Free
Home/Filings/4/0001169232-09-003555
4//SEC Filing

SUN PHARMA GLOBAL INC 4

Accession 0001169232-09-003555

CIK 0000887708other
View on SEC.govCompany Profile

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 4:01 PM ET

Size

13.7 KB

Accession

0001169232-09-003555

Insider Transaction Report

Form 4
Period: 2009-07-30
CARACO PHARMACEUTICAL LABORATORIES LTDCPD
SUN PHARMACEUTICAL INDUSTRIES LTD
10% Owner
Transactions
  • Conversion

    Common Stock

    2009-07-30+1,088,000→ 20,998,014 total(indirect: See Footnote)
  • Conversion

    Series B. Preferred Stock

    2009-07-30−544,000→ 1,632,000 total(indirect: See Footnote)
    Exercise: $0.00From: 2009-07-10→ Common Stock (544,000 underlying)
Holdings

  • Common Stock

    8,382,666
SHANGHVI DILIP S
Director(Non-Executive) Chairman
Transactions
  • Conversion

    Series B. Preferred Stock

    2009-07-30−544,000→ 1,632,000 total(indirect: See Footnote)
    Exercise: $0.00From: 2009-07-10→ Common Stock (544,000 underlying)
  • Conversion

    Common Stock

    2009-07-30+1,088,000→ 20,998,014 total(indirect: See Footnote)
Holdings

  • Common Stock

    8,382,666
SUN PHARMA GLOBAL INC
10% Owner
Transactions
  • Conversion

    Common Stock

    2009-07-30+1,088,000→ 20,998,014 total(indirect: See Footnote)
  • Conversion

    Series B. Preferred Stock

    2009-07-30−544,000→ 1,632,000 total(indirect: See Footnote)
    Exercise: $0.00From: 2009-07-10→ Common Stock (544,000 underlying)
Holdings

  • Common Stock

    8,382,666
Footnotes (3)
  • [F1]The Series B preferred shares converted into Common Stock on a one-to-one basis and had no expiration date.
  • [F2]These shares are owned directly by Sun Pharma Global, Inc., which is a wholly-owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun"). Dilip S. Shanghvi is the controlling shareholder of Sun. Sun and Mr. Shanghvi disclaim beneficial ownership of the reported shares except to the extent of their respective pecuniary interests therein.
  • [F3]These shares are owned directly by Sun. Dilip S. Shanghvi is the controlling shareholder of Sun. Mr. Shanghvi disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

CARACO PHARMACEUTICAL LABORATORIES LTD

CIK 0000887708

→
Entity typeother

Related Parties

1
  • filerCIK 0001197088

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:01 PM ET
Size
13.7 KB
View on SEC.gov